The kallikrein/kinin system in ocular function

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 6, 2011, Pages 539-543

  Webb, Jerry G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; KALLIDIN; KALLIKREIN; KININ; KININOGEN;

BLOOD CLOTTING; BLOOD FLOW; DIABETIC RETINOPATHY; ENDOTHELIUM; ENZYME SPECIFICITY; HOMEOSTASIS; HUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RETINA EDEMA; REVIEW; TISSUE DISTRIBUTION; TRABECULAR MESHWORK; VISUAL SYSTEM FUNCTION;

ANIMALS; EYE; HUMANS; KALLIKREINS; KININS; OCULAR PHYSIOLOGICAL PHENOMENA; SIGNAL TRANSDUCTION;

EID: 83455203578     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0187     Document Type: Review

References (46)

1. Bhoola, K.D., Figueroa, C.D., and Worthy, K. Bioregulation of kinins: Kallikreins, kininogens and kininases. Pharmacol. Rev. 44:1-80, 1992.
2. Joseph, K., and Kaplan, A.P. Formation of bradykinin: A major contributor to the innate inflammatory response. Adv. Immunol. 86:159-208, 2005. (Pubitemid 40215693)
3. Gailani, D., and Renne, T. The intrinsic pathway of coagulation: A target for treating thromboembolic disease. J. Thromb. Haemost. 5:1106-1112, 2007. (Pubitemid 46902107)
4. Slim, R., Torremocha, F., Moreau, T., et al. Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. J. Am. Soc. Nephrol. 13:968-976, 2002. (Pubitemid 34274093)
5. Motta, G., Rojkjaer, R. Hasan, A.A.K., Cines, D.B., and Schmaier, A.H. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood 91:516-528, 1998. (Pubitemid 28053374)
6. Shariat-Madar, Z., Mahdi, F., and Schmaier, A.H. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277: 17962-17969, 2002. (Pubitemid 34967607)
7. Schmaier, A.H., and McCrae, K.R. The plasma kallikreinkinin system: its evolution from contact activation. J. Thromb. Haemost. 5:2323-2329, 2007. (Pubitemid 350154338)
8. Leeb-Lundberg, L.M., Marceau, F., Muller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57:27-77, 2005. (Pubitemid 40283969)
9. Blais Jr., C. Marceau, F., Rouleau, J.-L., and Adam, A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides 21:1903-1940, 2000. (Pubitemid 32058866)
10. Zhang, X., Tan, F., Zhang, Y., and Skidgel, R.A. Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists. J. Biol. Chem. 283: 7994-8004, 2008.
11. Davis 3rd, A.E., Mejia, P., and Lu, F. Biological activities of C1 inhibitor. Mol. Immunol. 45:4057-4063, 2008.
12. Zhou, G., Chao, L., and Chao, J. Kallistatin: A novel human tissue kallikrein inhibitor. J. Biol. Chem. 267:25873-25880, 1992.
13. Phipps, J.A., Clermont, A.C., Sinha, S., et al. Plasma kallikrein mediates angiotensin II type I receptor-stimulated retinal vascular permeability. Hypertension 53:175-181, 2009.
14. Jeppesen, P., Aalkjaer, C., and Bek, T. Bradykinin relaxation in small porcine retinal arterioles. Invest. Ophthalmol. Vis. Sci. 43:1891-1896, 2002. (Pubitemid 34587037)
15. Ma, J.X., Song, Q., Hatcher, H.C., et al. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp. Eye Res. 63:19-26, 1996. (Pubitemid 26258796)
16. Gao, B.B., Clermont, A., Rook, S., et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13:181-188, 2007.
17. Gao, B.B., Chen, X., Timothy, N., Aiello, L.P., and Feener, E.P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J. Proteome Res. 7:2516-2525, 2008.
18. Krogsaa, B., Lund-Andersen, H., Mehlsen, J., Sestoft, L, and Larsen, J. The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol. 59:689-694, 1981. (Pubitemid 11026979)
19. Frank, R.M. Diabetic retinopathy. N. Engl. J. Med. 350:48-58, 2004.
20. Clermont, A., Chilcote, T.J., Kita, T., et al. Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes 60:1590-1598, 2011.
21. Schneider, L., Lumry, W. Vegh, A., Williams, A.H., and Schmalbach, T. Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor. J. Allergy Clin. Immunol. 120:416-422, 2007. (Pubitemid 47102386)
22. Zuraw, B., Cicardi, M., Levy, R.J., et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J. Allergy Clin. Immunol. 126:821-827, 2010.
23. Bork, K., Frank, J., Grundt, B., et al. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J. Allergy Clin. Immunol. 119:1497-1503, 2007. (Pubitemid 46855846)
24. Nussberger, J., Cugno, M. Amstutz, C., et al. Plasma bradykinin in angio-oedema. Lancet 351:1693-1697, 1998. (Pubitemid 28254530)
25. Kaplan, A.P., and Joseph, K. The bradykinin-forming cascade and its role in hereditary angiodema. Ann. Allergy Asthma Immunol. 104:193-204, 2010.
26. Pinna, A., Emanueli, C., Dore, S., et al. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. Ophthalmologica 218:260-263, 2004. (Pubitemid 38969833)
27. Webb, J.G., Yang, X., and Crosson, C.E. Expression of the kallikrein/kinin system in human anterior segment. Exp. Eye Res. 89:126-132, 2009.
28. Chowdhury, U.R., Madden, B.J., Charlesworth, M.C., and Fautsch, M.P. Proteome analysis of human aqueous humor. Invest. Ophthalmol. Vis. Sci. 51:4921-4931, 2010.
29. Barsotti, M.F., Bartels, S.P., Freddo, T.F., and Kamm, R.D. The source of protein in the aqueous humor of the normal monkey eye. Invest. Ophthalmol. Vis. Sci. 33:581-595, 1992.
30. Bert, R.J., Caruthers, S.D., Jara, H., et al. Demonstration of an anterior diffusional pathway for solutes in the normal human eye with high spatial resolution contrast-enhanced dynamic MR imaging. Invest. Ophthalmol. Vis. Sci. 47:5153-5162, 2006. (Pubitemid 46723757)
31. Sharif, N.A., and Xu, S.X. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp. Eye Res. 63:631-637, 1996. (Pubitemid 27021468)
32. Llobet, A., Gual, A., Pales, J., et al. Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro. Invest Ophthalmol. Vis. Sci. 40:113-125, 1999. (Pubitemid 29029579)
33. 2 signaling in bovine trabecularmeshwork cells. Exp. EyeRes. 76:283-289, 2003. (Pubitemid 36263327)
34. Webb, J.G., Yang, X., and Crosson, C.E. Bradykinin activation of extracellular signal-regulated kinases in human trabecular meshwork cells. Exp. Eye Res. 92:495-501, 2011.
35. Polansky, J.R., Kurtz, R.M., Alvarado, J.A., Weinreb, R.N., and Mitchell, M.D. Eicosanoid production and glucocorticoid regulatory mechanisms in cultured human trabecular meshwork cells. Prog. Clin. Biol. Res. 312:113-138, 1989.
36. (+)-channels. Invest. Ophthalmol. Vis. Sci. 38:1761-1767, 1997. (Pubitemid 27382341)
37. Webb, J.G., Husain, S., Yates, P.W., and Crosson, C.E. Kinin modulation of conventional outflow facility in the bovine eye. J. Ocul. Pharmacol. Ther. 22:310-316, 2006. (Pubitemid 44706522)
38. Meneton, P., Bloch-Faure, M., Hagege, A.A., et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc. Natl. Acad. Sci. USA 98:2634-2639, 2001. (Pubitemid 32209534)
39. Bergaya, S., Meneton, P., Bloch-Faure, M., et al. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ. Res. 88:593-599, 2001. (Pubitemid 32275795)
40. Bergaya, S., Matrougui, K., Meneton, P., Henrion, D., and Boulanger, C.M. Role of tissue kallikrein in response to flow in mouse resistance arteries. J. Hypertens. 22:745-750, 2004. (Pubitemid 38543566)
41. Azizi, M., Boutouyrie, P., Bissery, A., et al. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J. Clin. Invest. 115:780-787, 2005. (Pubitemid 40322255)
42. Griol-Charhbili, V., Messadi-Laribi, E., Bascands, J.L., et al. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J. 19:1172-1174, 2005. (Pubitemid 40946455)
43. 2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 104:7576-7581, 2007. (Pubitemid 47185948)
44. Messadi-Laribi, E., Griol-Charhbili, V., Gaies, E., et al. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia inmice. Clin. Exp. Pharmacol. Physiol. 35:489-493, 2008. (Pubitemid 351326785)
45. Roth, S., Li, B., Rosenbaum, P.S., et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest. Ophthalmol. Vis. Sci. 39:775-785, 1998.
46. Roth, S. Endogenous neuroprotection in the retina. Brain Res. Bull. 62:461-466, 2004. (Pubitemid 38253029)